CCM Duopharma Biotech Bhd (CCMDBIO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CCM Duopharma Biotech Bhd (CCMDBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3490
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CCM Duopharma Biotech Bhd (CCMD), a subsidiary of Chemical Company of Malaysia Bhd, is a pharmaceutical company that develops, manufactures and markets generic drugs and branded pharmaceutical products. The company offers products in the form of tablets, capsules, syrup, oral antibiotic, creams, haemodialysis solution, sterile irrigation solution, sterile powder injectables, small volume injectables, dental cartridges and eye drop preparations. It also manufactures small volume injectables through its manufacturing facility in Klang. CCMD exports its products across Vietnam, Ethiopia, Sudan, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore and Hong Kong. The company operates through its subsidiaries in the Philippines, Indonesia and Singapore. CCM Duopharma is headquartered in Klang, Malaysia.

CCM Duopharma Biotech Bhd (CCMDBIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Duopharma Enters into Agreement with PanGen Biotech 10
Licensing Agreements 11
Biocon Enters Into Licensing Agreement With CCM Pharma For Insulin Products 11
Equity Offering 12
CCM Duopharma Biotech Prices Rights Offering of Shares for USD75 Million 12
Acquisition 13
CCM Duopharma Biotech to Acquire 8.39% Stake in Pangen Biotech from Chemical Company of Malaysia for USD9.4 Million 13
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 15
CCM Duopharma Biotech Bhd – Key Competitors 17
CCM Duopharma Biotech Bhd – Key Employees 18
CCM Duopharma Biotech Bhd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Feb 24, 2017: CCM Duopharma Registers Double-Digit Top Line Growth In FY 2016 21
Other Significant Developments 22
May 22, 2017: CCM Duopharma Aims To Become A Leading Regional Player 22
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CCM Duopharma Biotech Bhd, Deals By Therapy Area, 2012 to YTD 2018 8
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duopharma Enters into Agreement with PanGen Biotech 10
Biocon Enters Into Licensing Agreement With CCM Pharma For Insulin Products 11
CCM Duopharma Biotech Prices Rights Offering of Shares for USD75 Million 12
CCM Duopharma Biotech to Acquire 8.39% Stake in Pangen Biotech from Chemical Company of Malaysia for USD9.4 Million 13
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 15
CCM Duopharma Biotech Bhd, Key Competitors 17
CCM Duopharma Biotech Bhd, Key Employees 18
CCM Duopharma Biotech Bhd, Subsidiaries 19

List of Figures
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CCM Duopharma Biotech Bhd (CCMDBIO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Tanami Gold NL:企業の戦略・SWOT・財務分析
    Tanami Gold NL - Strategy, SWOT and Corporate Finance Report Summary Tanami Gold NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Wingstop Inc.:企業の戦略・SWOT・財務情報
    Wingstop Inc. - Strategy, SWOT and Corporate Finance Report Summary Wingstop Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sohu.com Inc. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Inc. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Orlando Utilities Commission:電力:M&Aディール及び事業提携情報
    Summary Orlando Utilities Commission (OUC) is a municipally-owned public utility that provides water and electric services. The commission generates, transmits, and distributes electricity and water to residential and commercial customers. It also constructs, operates and maintains electric and wate …
  • Dune Medical Devices Ltd:企業の製品パイプライン分析2018
    Summary Dune Medical Devices Ltd (Dune Medical), a subsidiary of Dune Medical Devices Inc, is a medical device company that offers diagnostic products. The company develops, manufactures, and commercializes tissue characterization devices including MarginProbe system that provides assessment of the …
  • Walchandnagar Industries Ltd:企業の戦略・SWOT・財務分析
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Elips Versicherungen AG:企業の戦略的SWOT分析
    Elips Versicherungen AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Florida Power & Light Co:企業の発電所・SWOT分析2018
    Florida Power & Light Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Rutgers The State University of New Jersey-医療機器分野:企業M&A・提携分析
    Summary Rutgers The State University of New Jersey (Rutgers) is a research university that offers undergraduate and postgraduate programs, and research in the areas of health sciences. The university provides continuing education for professional and personal advancement. It offers courses in the ar …
  • BreitBurn Energy Partners L.P. (BBEP)-石油・ガス分野:企業M&A・提携分析
    Summary BreitBurn Energy Partners L.P. (BreitBurn Energy) is an independent upstream oil and gas partnership company that acquires assets, and explores, develops and produces oil and gas properties in the US. The company’s asset portfolio consist of producing and non-producing oil, Natural Gas Liqui …
  • aTyr Pharma Inc (LIFE)-製薬・医療分野:企業M&A・提携分析
    Summary aTyr Pharma Inc (aTyr Pharma) is a biotherapeutics company that discovers and develops physiocrine-based therapies. The company’s resolaris is a potential intravenous protein therapeutic for the treatment of rare myopathies with an immune component. It offers phyisiocrine, which is a class o …
  • KDDI Corporation:企業の戦略・SWOT・財務情報
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Colfax Corp (CFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Colfax Corp (Colfax) is a manufacturing and engineering company. The company supplies a wide range of products, including heavy-duty centrifugal and axial fans, gas compressors, rotary heat exchangers, and centrifugal and positive displacement pumps; and consumable products and equipment for …
  • Enzon Pharmaceuticals Inc (ENZN):製薬・医療:M&Aディール及び事業提携情報
    Summary Enzon Pharmaceuticals Inc (Enzon), formerly Enzon, Inc., is a pharmaceutical company that receives royalty revenues from existing licensing arrangements. The company has licensing arrangements with other companies related to sales of their four marketed drug products, namely, PegIntron, Syla …
  • Family Dollar Stores, Inc.:企業の戦略・SWOT・財務情報
    Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Topaz Energy and Marine Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Topaz Energy and Marine Ltd (Topaz), a subsidiary of Renaissance Services SAOG, is an oil and gas company that offers offshore support vessels and marine solutions. The company's services include platform supply, anchor handling, emergency recovery and response and crew transfer. It operates …
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Banco Occidental de Descuento:企業の戦略・SWOT・財務情報
    Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report Summary Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Biovica International AB-医療機器分野:企業M&A・提携分析
    Summary Biovica International AB (Biovica) is a biotech company that develops biomarkers for conducting diagnosis and monitoring the cancer patient’s .The company’s DiviTum is a sensitive assay, which is used for measuring activity of thymidine kinase, an enzyme associated with cell proliferation, i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆